Cargando…

Characterization of ERM transactivation domain binding to the ACID/PTOV domain of the Mediator subunit MED25

The N-terminal acidic transactivation domain (TAD) of ERM/ETV5 (ERM(38–68)), a PEA3 group member of Ets-related transcription factors, directly interacts with the ACID/PTOV domain of the Mediator complex subunit MED25. Molecular details of this interaction were investigated using nuclear magnetic re...

Descripción completa

Detalles Bibliográficos
Autores principales: Landrieu, Isabelle, Verger, Alexis, Baert, Jean-Luc, Rucktooa, Prakash, Cantrelle, François-Xavier, Dewitte, Frédérique, Ferreira, Elisabeth, Lens, Zoé, Villeret, Vincent, Monté, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538835/
https://www.ncbi.nlm.nih.gov/pubmed/26130716
http://dx.doi.org/10.1093/nar/gkv650
_version_ 1782386043549384704
author Landrieu, Isabelle
Verger, Alexis
Baert, Jean-Luc
Rucktooa, Prakash
Cantrelle, François-Xavier
Dewitte, Frédérique
Ferreira, Elisabeth
Lens, Zoé
Villeret, Vincent
Monté, Didier
author_facet Landrieu, Isabelle
Verger, Alexis
Baert, Jean-Luc
Rucktooa, Prakash
Cantrelle, François-Xavier
Dewitte, Frédérique
Ferreira, Elisabeth
Lens, Zoé
Villeret, Vincent
Monté, Didier
author_sort Landrieu, Isabelle
collection PubMed
description The N-terminal acidic transactivation domain (TAD) of ERM/ETV5 (ERM(38–68)), a PEA3 group member of Ets-related transcription factors, directly interacts with the ACID/PTOV domain of the Mediator complex subunit MED25. Molecular details of this interaction were investigated using nuclear magnetic resonance (NMR) spectroscopy. The TAD is disordered in solution but has a propensity to adopt local transient secondary structure. We show that it folds upon binding to MED25 and that the resulting ERM–MED25 complex displays characteristics of a fuzzy complex. Mutational analysis further reveals that two aromatic residues in the ERM TAD (F47 and W57) are involved in the binding to MED25 and participate in the ability of ERM TAD to activate transcription. Mutation of a key residue Q451 in the VP16 H1 binding pocket of MED25 affects the binding of ERM. Furthermore, competition experiments show that ERM and VP16 H1 share a common binding interface on MED25. NMR data confirms the occupancy of this binding pocket by ERM TAD. Based on these experimental data, a structural model of a functional interaction is proposed. This study provides mechanistic insights into the Mediator–transactivator interactions.
format Online
Article
Text
id pubmed-4538835
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-45388352015-08-18 Characterization of ERM transactivation domain binding to the ACID/PTOV domain of the Mediator subunit MED25 Landrieu, Isabelle Verger, Alexis Baert, Jean-Luc Rucktooa, Prakash Cantrelle, François-Xavier Dewitte, Frédérique Ferreira, Elisabeth Lens, Zoé Villeret, Vincent Monté, Didier Nucleic Acids Res Structural Biology The N-terminal acidic transactivation domain (TAD) of ERM/ETV5 (ERM(38–68)), a PEA3 group member of Ets-related transcription factors, directly interacts with the ACID/PTOV domain of the Mediator complex subunit MED25. Molecular details of this interaction were investigated using nuclear magnetic resonance (NMR) spectroscopy. The TAD is disordered in solution but has a propensity to adopt local transient secondary structure. We show that it folds upon binding to MED25 and that the resulting ERM–MED25 complex displays characteristics of a fuzzy complex. Mutational analysis further reveals that two aromatic residues in the ERM TAD (F47 and W57) are involved in the binding to MED25 and participate in the ability of ERM TAD to activate transcription. Mutation of a key residue Q451 in the VP16 H1 binding pocket of MED25 affects the binding of ERM. Furthermore, competition experiments show that ERM and VP16 H1 share a common binding interface on MED25. NMR data confirms the occupancy of this binding pocket by ERM TAD. Based on these experimental data, a structural model of a functional interaction is proposed. This study provides mechanistic insights into the Mediator–transactivator interactions. Oxford University Press 2015-08-18 2015-06-29 /pmc/articles/PMC4538835/ /pubmed/26130716 http://dx.doi.org/10.1093/nar/gkv650 Text en © The Author(s) 2015. Published by Oxford University Press on behalf of Nucleic Acids Research. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Structural Biology
Landrieu, Isabelle
Verger, Alexis
Baert, Jean-Luc
Rucktooa, Prakash
Cantrelle, François-Xavier
Dewitte, Frédérique
Ferreira, Elisabeth
Lens, Zoé
Villeret, Vincent
Monté, Didier
Characterization of ERM transactivation domain binding to the ACID/PTOV domain of the Mediator subunit MED25
title Characterization of ERM transactivation domain binding to the ACID/PTOV domain of the Mediator subunit MED25
title_full Characterization of ERM transactivation domain binding to the ACID/PTOV domain of the Mediator subunit MED25
title_fullStr Characterization of ERM transactivation domain binding to the ACID/PTOV domain of the Mediator subunit MED25
title_full_unstemmed Characterization of ERM transactivation domain binding to the ACID/PTOV domain of the Mediator subunit MED25
title_short Characterization of ERM transactivation domain binding to the ACID/PTOV domain of the Mediator subunit MED25
title_sort characterization of erm transactivation domain binding to the acid/ptov domain of the mediator subunit med25
topic Structural Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538835/
https://www.ncbi.nlm.nih.gov/pubmed/26130716
http://dx.doi.org/10.1093/nar/gkv650
work_keys_str_mv AT landrieuisabelle characterizationofermtransactivationdomainbindingtotheacidptovdomainofthemediatorsubunitmed25
AT vergeralexis characterizationofermtransactivationdomainbindingtotheacidptovdomainofthemediatorsubunitmed25
AT baertjeanluc characterizationofermtransactivationdomainbindingtotheacidptovdomainofthemediatorsubunitmed25
AT rucktooaprakash characterizationofermtransactivationdomainbindingtotheacidptovdomainofthemediatorsubunitmed25
AT cantrellefrancoisxavier characterizationofermtransactivationdomainbindingtotheacidptovdomainofthemediatorsubunitmed25
AT dewittefrederique characterizationofermtransactivationdomainbindingtotheacidptovdomainofthemediatorsubunitmed25
AT ferreiraelisabeth characterizationofermtransactivationdomainbindingtotheacidptovdomainofthemediatorsubunitmed25
AT lenszoe characterizationofermtransactivationdomainbindingtotheacidptovdomainofthemediatorsubunitmed25
AT villeretvincent characterizationofermtransactivationdomainbindingtotheacidptovdomainofthemediatorsubunitmed25
AT montedidier characterizationofermtransactivationdomainbindingtotheacidptovdomainofthemediatorsubunitmed25